research profile
Dr. Kristin Bradley’s Research
I participate in clinical research, evaluating ways to improve cancer care in patients with gynecologic, hematologic or pediatric cancers who are receiving radiation as a component of their treatment.
Last updated:
Novel Use of 0.35T ViewRay MRI-guidance for High Dose Rate Brachytherapy in the Treatment of Cervical Cancer
Image-guided adaptive brachytherapy for cervical cancer has resulted in improved outcomes and/or decreased toxicity rates for many cervical patients compared to prior 2D/fluoroscopic-based planning. We sought to evaluate the 0.35T MRI on our ViewRay system for brachytherapy and to compare dosimetry, time to treatment and image quality relative to diagnostic MRI and CT.
We presented our findings in abstract form at ASTRO 2017 and manuscript has been submitted.
Severe Late Toxicities Following Concomitant Chemoradiotherapy Compared to Radiotherapy Alone in Cervical Cancer: An Inter-Era Analysis
We sought to compare rates of severe late toxicities following concomitant chemoradiotherapy and radiotherapy alone for cervical cancer. We found that compared to radiotherapy alone, concomitant chemoradiotherapy is associated with higher rates of severe vaginal and skeletal late toxicities.